Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Endothelial-to-Mesenchymal Transition in Cancer

Abstract : Cancer is one of the most important causes of morbidity and mortality worldwide. Tumor cells grow in a complex microenvironment constituted of immune, stromal, and vascular cells that supports growth, angiogenesis, and metastasis. Endothelial cells (ECs) are major components of the vascular microenvironment. These cells have been described for their plasticity and potential to transdifferentiate into mesenchymal cells through a process known as endothelial-to-mesenchymal transition (EndMT). This complex process is controlled by various factors, by which ECs convert into a phenotype characterized by mesenchymal protein expression and motile, contractile morphology. Initially described in normal heart development, EndMT is now identified in several pathologies, and especially in cancer. In this review, we highlight the process of EndMT in the context of cancer and we discuss it as an important adaptive process of the tumor microenvironment that favors tumor growth and dissemination but also resistance to treatment. Thus, we underline targeting of EndMT as a potential therapeutic strategy.
Type de document :
Article dans une revue
Liste complète des métadonnées

Littérature citée [80 références]  Voir  Masquer  Télécharger
Contributeur : Nicolas Clere <>
Soumis le : mardi 20 octobre 2020 - 08:21:10
Dernière modification le : mardi 20 octobre 2020 - 09:28:28


Fichiers éditeurs autorisés sur une archive ouverte


Distributed under a Creative Commons Paternité 4.0 International License



Nicolas Clere, Sarah Renault, Isabelle Corre. Endothelial-to-Mesenchymal Transition in Cancer. Frontiers in Cell and Developmental Biology, Frontiers media, 2020, 8 (747), pp.1-8. ⟨10.3389/fcell.2020.00747⟩. ⟨hal-02917778⟩



Consultations de la notice


Téléchargements de fichiers